1. Luo, Jie, Cao, Jingsong, Chen, Cong, Xie, Haitao. 2023. Emerging role of RNA acetylation modification ac4C in diseases: Current advances and future challenges. In Biochemical pharmacology, 213, 115628. doi:10.1016/j.bcp.2023.115628. https://pubmed.ncbi.nlm.nih.gov/37247745/
2. Broly, Martin, Polevoda, Bogdan V, Awayda, Kamel M, Cogné, Benjamin, O'Connell, Mitchell R. 2022. THUMPD1 bi-allelic variants cause loss of tRNA acetylation and a syndromic neurodevelopmental disorder. In American journal of human genetics, 109, 587-600. doi:10.1016/j.ajhg.2022.02.001. https://pubmed.ncbi.nlm.nih.gov/35196516/
3. Chen, Qinggui, Lin, Li, Xiong, Boliang, Shi, Huibo, Wang, Zhenfa. . MiR-873-5p targets THUMPD1 to inhibit gastric cancer cell behavior and chemoresistance. In Journal of gastrointestinal oncology, 12, 2061-2072. doi:10.21037/jgo-21-641. https://pubmed.ncbi.nlm.nih.gov/34790374/
4. Li, Kuangxun, Liu, Junzhe, Yang, Xinyu, Huang, Kai, Zhu, Xingen. . Pan-cancer analysis of N4-acetylcytidine adaptor THUMPD1 as a predictor for prognosis and immunotherapy. In Bioscience reports, 41, . doi:10.1042/BSR20212300. https://pubmed.ncbi.nlm.nih.gov/34762107/
智鼠故事 
